Porocel

 

News and Articles



Porocel purchases Canadian catalyst plant and processing facility

01.23.2014

Porocel of Canada, Ltd announces the acquisition of the Medicine Hat (Alberta) catalyst processing plant from Criterion Catalysts & Technologies Canada, Inc (“Criterion”).    Porocel of Canada, Ltd is a wholly-owned subsidiary of Porocel International, LLC (“Porocel”).


The Medicine Hat facility will be Porocel’s fourth catalyst regeneration, rejuvenation and ex-situ presulphurization plant globally, adding to its other sites:  Lafayette (Louisiana), Luxembourg and Singapore.   This acquisition strategically positions Porocel to service the growing Canadian catalyst market.   The company will achieve growth with a focused, continued emphasis on HSE, and will be introducing new and innovative technologies tied to catalyst regeneration,  rejuvenation, ex-situ presulphurization and other related catalyst processing technologies.


We look forward to having Medicine Hat in our portfolio, and to a safe & prosperous future operating in Canada.


Contact        
Terence J. McHugh      
(281) 469-0500
Chief Operating Officer, Porocel

 

Canada contact
Lyle Anderson, Plant Manager
Email:  landerson@porocel.com
Tel:      (1) 403-527-4400
Porocel of Canada, Ltd

 



« back